Single autologous stem-cell transplantation followed by maintenance therapy with thalidomide is superior to double autologous transplantation in multiple myeloma: results of a multicenter randomized clinical trial From April 2003 to December 2006, 195 patients with de novo symptomatic myeloma and younger than 60 years of age were randomly assigned ... (more)
http://ift.tt/1pJNcMX
http://ift.tt/1pJNcMX
No comments:
Post a Comment